1-2 of 2
Anna Rozova
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data

Clinical Trials & Observations
Sherif M. Badawy, Jan Palmblad, Fernando Tricta, Noemi Toiber Temin, Caroline Fradette, Leo Lin, Anna Rozova, Sujit Sheth
Journal: Blood Advances
Blood Adv (2024) 8 (21): 5641–5649.
https://doi.org/10.1182/bloodadvances.2023012316
Published: 2024
Journal Articles

Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years

Clinical Trials & Observations
Mohsen S. Elalfy, Mona Hamdy, Amal El-Beshlawy, Fatma S. E. Ebeid, Mohamed Badr, Julie Kanter, Baba Inusa, Amira A. M. Adly, Suzan Williams, Yurdanur Kilinc, David Lee, Caroline Fradette, Anna Rozova, Noemi Toiber Temin, Fernando Tricta, Janet L. Kwiatkowski
Journal: Blood Advances
Blood Adv (2023) 7 (4): 611–619.
https://doi.org/10.1182/bloodadvances.2021006778
Published: 2023
Includes: Supplemental data